tiprankstipranks
Trending News
More News >
Harvard Apparatus Regenerative Technology (HRGN)
OTHER OTC:HRGN
US Market

Harvard Apparatus Regenerative Technology (HRGN) Income Statement

Compare
104 Followers

Harvard Apparatus Regenerative Technology Income Statement

Last quarter (Q4 2025), Harvard Apparatus Regenerative Technology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Harvard Apparatus Regenerative Technology's net income was $-1.69M. See Harvard Apparatus Regenerative Technology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -646.00K$ -270.00K$ -24.00K$ 0.00$ 0.00
Operating Expenses
$ 6.97M$ 7.89M$ 9.07M$ 6.15M$ 8.47M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 50.00K$ -258.00K
EBITDA
$ -7.62M$ -8.16M$ -9.09M$ -5.92M$ -8.89M
Operating Income
$ -7.62M$ -8.16M$ -9.09M$ -6.15M$ -8.64M
Other Income/Expenses
$ 750.00K$ 424.00K$ 71.00K$ 80.00K$ 658.00K
Pretax Income
$ -6.87M$ -7.73M$ -9.02M$ -6.07M$ -7.98M
Net Income
$ -6.87M$ -7.73M$ -9.02M$ -6.07M$ -7.98M
Per Share Metrics
Basic EPS
$ -0.42$ -0.52$ -0.67$ -0.55$ -0.74
Diluted EPS
$ -0.42$ -0.52$ -0.67$ -0.55$ -0.74
Weighted Average Shares Outstanding
16.52M 14.79M 13.46M 11.35M 10.06M
Weighted Average Shares Outstanding (Diluted)
16.52M 14.79M 13.46M 11.35M 10.06M
Currency in USD

Harvard Apparatus Regenerative Technology Earnings and Revenue History